- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 207/16 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 207/16
Total number of patents in this class: 1158
10-year publication summary
|
97
|
89
|
98
|
84
|
105
|
112
|
102
|
68
|
65
|
21
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7958 |
32 |
| Novartis AG | 11238 |
18 |
| Bristol-myers Squibb Company | 5080 |
17 |
| Givaudan SA | 1760 |
16 |
| President and Fellows of Harvard College | 5792 |
13 |
| Epics Therapeutics | 16 |
13 |
| Hoffmann-La Roche Inc. | 3060 |
12 |
| Life Technologies Corporation | 3068 |
12 |
| Biogen MA Inc. | 926 |
11 |
| Ono Pharmaceutical Co., Ltd. | 454 |
11 |
| Aichi Steel Corporation | 333 |
10 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
10 |
| Abbvie Inc. | 1808 |
9 |
| Astellas Pharma Inc. | 1145 |
9 |
| Cytokinetics, Inc. | 259 |
9 |
| Tokushima University | 184 |
9 |
| Xwpharma Ltd. | 56 |
9 |
| Massachusetts Institute of Technology | 9795 |
8 |
| Omeros Corporation | 286 |
8 |
| The Regents of the University of California | 18943 |
7 |
| Other owners | 915 |